Works matching IS 15430790 AND DT 2018 AND VI 16 AND IP 6
Results: 11
Contemporary Management of Advanced Renal Cell Carcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 438
- By:
- Publication type:
- Article
Management of Newly Diagnosed or Recurrent Ovarian Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 426
- By:
- Publication type:
- Article
Highlights in Kidney Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 423
- Publication type:
- Article
Cellular Immunotherapy for Non-Hodgkin Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 420
- By:
- Publication type:
- Article
A Closer Look at Blinatumomab.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 412
- By:
- Publication type:
- Article
Bipolar Androgen Therapy in the Treatment of Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 408
- By:
- Publication type:
- Article
Additional Approvals.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 397
- Publication type:
- Article
Tisagenlecleucel Approved in Relapsed/Refractory Large B-Cell Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 397
- By:
- Publication type:
- Article
FDA Approves Adjuvant Dabrafenib/Trametinib in BRAF-Mutated Melanoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 397
- By:
- Publication type:
- Article
Osimertinib Approved for First-Line Treatment in Metastatic NSCLC.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 397
- By:
- Publication type:
- Article
The Fast-Changing World of CLL.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 6, p. 396
- By:
- Publication type:
- Article